Results 231 to 240 of about 432,090 (383)

Management of Immune Thrombocytopenia via Splenectomy in a Full-Term Pregnant Woman: A Case Report. [PDF]

open access: yesInt Med Case Rep J
Doyya M   +5 more
europepmc   +1 more source

All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement–interleukin-1β loop

open access: gold, 2019
Xiaolu Zhu   +12 more
openalex   +2 more sources

Klippel‐Trénaunay‐Weber Syndrome: Prenatal Diagnosis and Review of the Literature

open access: yesJournal of Clinical Ultrasound, Volume 53, Issue 3, Page 535-546, March/April 2025.
This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.
Giuliana Orlandi   +13 more
wiley   +1 more source

Venom-Induced Recurrent Thrombocytopenia: A Model of Intervention-Driven Platelet Modulation. [PDF]

open access: yesToxins (Basel)
Dobaja Borak M   +5 more
europepmc   +1 more source

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

open access: gold, 2021
Sara Bonato   +10 more
openalex   +2 more sources

Clinical progress note: Rubella

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad.
Adam E. Gailani   +2 more
wiley   +1 more source

Methotrexate toxicity and intolerance in paediatric inflammatory bowel disease: A retrospective cohort study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Methotrexate (MTX) is frequently prescribed in paediatric inflammatory bowel disease (IBD), with routine laboratory monitoring to detect adverse events (AEs), such as hepatotoxicity and myelotoxicity. However, data on the incidence and predictors of these AEs remain limited.
Eva Vermeer   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy